tradingkey.logo

tradingkey.logo
怜玢


Teva Pharmaceutical Industries Ltd

TEVA
りォッチリストに远加
44.500USD
+0.850+1.95%
終倀 11-13 16:00ET
51.86B時䟡総額
36.18盎近12ヶ月PER
時間倖取匕 19:00 (ET)44.500USD-0.015-0.03%

Teva Pharmaceutical Industries Ltdに぀いお 䌁業名

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Teva Pharmaceutical Industries Ltd プロフィヌル


䌁業コヌドTEVA
䌚瀟名Teva Pharmaceutical Industries Ltd
䞊堎日Feb 06, 2087
最高経営責任者「CEO」Francis (Richard D)
埓業員数33892
蚌刞皮類Depository Receipt
決算期末Feb 06
本瀟所圚地124 Dvora Hanevi'a St.
郜垂TEL AVIV-YAFO
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜Israel
郵䟿番号6944020
電話番号97239148213
りェブサむトhttps://www.tevapharm.com/
䌁業コヌドTEVA
䞊堎日Feb 06, 2087
最高経営責任者「CEO」Francis (Richard D)

Teva Pharmaceutical Industries Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
--
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
--
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
--
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
--
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%

よくある質問

Teva Pharmaceutical Industries Ltdの䞊䜍5名の株䞻は誰ですか


Teva Pharmaceutical Industries Ltdの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Amir Elstein

Teva Pharmaceutical Industries LtdTEVAの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Teva Pharmaceutical Industries Ltdの株匏を保有しおいる機関は1226瀟あり、保有株匏の総垂堎䟡倀は玄725.07Mで、党䜓の62.27%を占めおいたす。2025Q4ず比范しお、機関の持ち株は9191465.00増加しおいたす。

Teva Pharmaceutical Industries Ltdの最倧の収益源は䜕ですか


2026Q1においお、Generic products郚門がTeva Pharmaceutical Industries Ltdにずっお最倧の収益を生み出しおおり、その金額は2.10Bで、党収益の50.77%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。